These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3039052)

  • 1. Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS.
    Farthing C; Anderson MG; Ellis ME; Gazzard BG; Chanas AC
    J Med Virol; 1987 Jun; 22(2):157-62. PubMed ID: 3039052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).
    Walmsley SL; Chew E; Read SE; Vellend H; Salit I; Rachlis A; Fanning MM
    J Infect Dis; 1988 Mar; 157(3):569-72. PubMed ID: 2830347
    [No Abstract]   [Full Text] [Related]  

  • 3. Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Jacobson MA; O'Donnell JJ; Mills J
    Antimicrob Agents Chemother; 1989 May; 33(5):736-41. PubMed ID: 2546490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foscarnet for cytomegalovirus pneumonitis.
    Apperley JF; Marcus RE; Goldman JM; Wardle DG; Gravett PJ; Chanas A
    Lancet; 1985 May; 1(8438):1151. PubMed ID: 2860348
    [No Abstract]   [Full Text] [Related]  

  • 5. Foscarnet for cytomegalovirus retinitis.
    Singer DR; Fallon TJ; Schulenburg WE; Williams G; Cohen J
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):962. PubMed ID: 2998255
    [No Abstract]   [Full Text] [Related]  

  • 6. [Importance of Foscarnet in the treatment of cytomegalovirus pneumopathy in a patient with acquired immunodeficiency syndrome].
    Brochard L; Salmeron S; Herve P; Petitpretz P; Boissonnas A; Simonneau G; Duroux P
    Presse Med; 1986 Nov; 15(40):2022-3. PubMed ID: 3025830
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
    Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J
    J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921
    [No Abstract]   [Full Text] [Related]  

  • 8. Foscarnet.
    Med Lett Drugs Ther; 1992 Jan; 34(861):3-4. PubMed ID: 1309469
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis.
    Jacobson MA; Mills J; Rush J; O'Donnell JJ; Miller RG; Greco C; Gonzales MF
    Arch Neurol; 1988 Oct; 45(10):1090-2. PubMed ID: 2845899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of cytomegalovirus infections in immunosuppressed patients].
    Michon C; Girard PM; Ngovan P; Simonpoli AM; Le Hoang P
    Ann Med Interne (Paris); 1988; 139(7):511-5. PubMed ID: 2854380
    [No Abstract]   [Full Text] [Related]  

  • 11. Fixed drug eruption due to foscarnet.
    Connolly GM; Gazzard BG; Hawkins DA
    Genitourin Med; 1990 Apr; 66(2):97-8. PubMed ID: 2160425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection in the acquired immune deficiency syndrome.
    Pinching AJ
    J Antimicrob Chemother; 1989 Jun; 23 Suppl E():31-6. PubMed ID: 2550410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of CMV retinitis.
    Deray G; Katlama C; Jacobs C
    N Engl J Med; 1992 Jun; 326(25):1702. PubMed ID: 1317011
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of acquired immune deficiency syndrome (AIDS)-related pneumonitis with foscarnet: a double-blind placebo controlled study.
    Youle M; Chanas A; Gazzard B
    J Infect; 1990 Jan; 20(1):41-50. PubMed ID: 2153728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.
    Ganly PS; Arthur C; Goldman JM; Schulenburg WE
    Postgrad Med J; 1988 May; 64(751):389-91. PubMed ID: 2849092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and prophylaxis of cytomegalovirus disease.
    Levinson ML; Jacobson PA
    Pharmacotherapy; 1992; 12(4):300-18. PubMed ID: 1325636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.
    MacGregor RR; Graziani AL; Weiss R; Grunwald JE; Gambertoglio JG
    J Infect Dis; 1991 Oct; 164(4):785-7. PubMed ID: 1654363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate).
    Weber JN; Thom S; Barrison I; Unwin R; Forster S; Jeffries DJ; Boylston A; Pinching AJ
    Gut; 1987 Apr; 28(4):482-7. PubMed ID: 3034745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients.
    Ringdén O; Lönnqvist B; Paulin T; Ahlmén J; Klintmalm G; Wahren B; Lernestedt JO
    J Antimicrob Chemother; 1986 Mar; 17(3):373-87. PubMed ID: 3009383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS.
    Enting R; de Gans J; Reiss P; Jansen C; Portegies P
    Lancet; 1992 Aug; 340(8818):559-60. PubMed ID: 1354319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.